Finance

Lists
Why is SGMT down 8,70%?
Dive Deeper
SGMT:NASDAQ
Sagimet Biosciences Inc
US$8,03
-8,70%
(-0,77) 1D
13 ຕ.ລ., 12 ໂມງ 15 ນາທີ 51 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SGMT...
Open
US$8,70
High
US$8,74
Low
US$8,02
Mkt. cap
566,66 ລ້ານ
Avg. vol.
1,31 ລ້ານ
Volume
971,92 ພັນ
52-wk high
US$11,45
52-wk low
US$4,50
EPS
US$-1,28
Beta
3,46
Shares outstanding
70,34 ລ້ານ
No. of employees
16
Open
US$8,70
High
US$8,74
Low
US$8,02
Mkt. cap
566,66 ລ້ານ
Avg. vol.
1,31 ລ້ານ
Volume
971,92 ພັນ
52-wk high
US$11,45
52-wk low
US$4,50
EPS
US$-1,28
Beta
3,46
Shares outstanding
70,34 ລ້ານ
No. of employees
16
News stories
From web sources and news partners
About Sagimet Biosciences Inc
CEO-
Employees16
Founded2006
HeadquartersSan Mateo, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorBiotechnology
Websitesagimet.com
Analyst ratings
Based on 12 analysts giving stock ratings to SGMT in the past 3 months
Strong buy
Buy
11
Hold
0
Sell
1
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for SGMT in the last 3 months.
Highest
Current US$8,03
US$56,00 (+597,04%)
Average
US$28,46 (+254,24%)
Lowest
US$7,00 (-12,87%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
US$29,00
+261%
10/05/2026
Seamus Fernandez
Guggenheim
Buy
Reiterated
US$26,00
+223,6%
10/01/2026
Thomas Smith
Leerink Partners
Buy
Reiterated
-
-
10/01/2026
Andrea Newkirk
Goldman Sachs
Sell
Maintained
US$7,00
-12,9%
09/30/2026
Jay Olson
Oppenheimer
Buy
Maintained
US$38,00
+373%
10/01/2026
Edward Nash
Canaccord Genuity
Buy
Reiterated
US$56,00
+597%
10/01/2026
Yanni Souroutzidis
Cantor Fitzgerald
Buy
Maintained
US$25,10
+212,4%
10/01/2026
Yun Zhong
Wedbush
Buy
Maintained
US$28,00
+248,5%
10/01/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
US$27,00
+236,1%
10/01/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
US$28,00
+248,5%
09/30/2026
Debanjana Chatterjee
JonesTrading
Buy
Reiterated
US$31,00
+285,9%
09/27/2026
Eliana Merle
Barclays
Buy
Upgraded
US$18,00
+124%
09/09/2026
Ritu Baral
TD Cowen
Buy
Maintained
US$21,00
+161,4%
05/12/2026
Unknown Analyst
Rodman & Renshaw
Buy
Initiated
US$28,00
+248,5%
03/26/2026
Seema Sheoran
Rodman & Renshaw
Buy
Initiated
US$28,00
+248,5%
03/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
9,73 ລ້ານ
6,73 ລ້ານ
7,00 ລ້ານ
11,54 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,60 ລ້ານ
4,03 ລ້ານ
4,72 ລ້ານ
4,28 ລ້ານ
Operating expense
14,33 ລ້ານ
10,76 ລ້ານ
11,71 ລ້ານ
15,82 ລ້ານ
Total operating expenses
14,33 ລ້ານ
10,76 ລ້ານ
11,71 ລ້ານ
15,82 ລ້ານ
Operating income
-14,33 ລ້ານ
-10,76 ລ້ານ
-11,71 ລ້ານ
-15,82 ລ້ານ
Other non operating income
-
-
-
-
EBT including unusual items
-12,91 ລ້ານ
-9,57 ລ້ານ
-10,65 ລ້ານ
-13,95 ລ້ານ
EBT excluding unusual items
-12,91 ລ້ານ
-9,57 ລ້ານ
-10,65 ລ້ານ
-13,95 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12,91 ລ້ານ
-9,57 ລ້ານ
-10,65 ລ້ານ
-13,95 ລ້ານ
Net profit margin
-
-
-
-
Earnings per share
-0,40
-0,29
-0,33
-0,26
Interest and investment income
1,43 ລ້ານ
1,20 ລ້ານ
1,06 ລ້ານ
1,86 ລ້ານ
Interest expense
-
-
-
-
Net interest expenses
1,43 ລ້ານ
1,20 ລ້ານ
1,06 ລ້ານ
1,86 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
ແອັບຂອງ Google